10x Genomics, Inc.
TXG
$27.25
-$0.23-0.84%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -53.67% | -33.56% | -20.91% | -95.69% | -185.11% |
| Total Depreciation and Amortization | 32.15% | 26.77% | 19.54% | 13.06% | 16.82% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 28.91% | 41.08% | 45.99% | 47.59% | 44.53% |
| Change in Net Operating Assets | 144.00% | 36.56% | 27.59% | 61.36% | 54.92% |
| Cash from Operations | 54.78% | 34.42% | 80.25% | 55.56% | -57.24% |
| Capital Expenditure | 63.09% | 28.99% | -2.93% | -19.37% | -30.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -66.67% | -- | -- | 26.62% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 184.61% | 177.85% | 169.61% | 160.46% | -- |
| Cash from Investing | 138.04% | 125.26% | 114.93% | 108.32% | -228.76% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -7.49% | -7.49% | -7.49% | -7.49% | -7.58% |
| Issuance of Common Stock | -8.21% | -24.90% | -44.46% | -60.11% | -47.36% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -13.58% | -33.78% | -55.99% | -70.80% | -55.19% |
| Foreign Exchange rate Adjustments | 25.00% | 137.40% | 180.57% | -108.70% | -118.80% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 135.78% | 119.91% | 113.37% | 106.08% | -298.31% |
